Will Medtronic plc report Above 7% cardiovascular organic revenue growth in Q1 2027?

One exact rung · Q1 2027

This contract observes one threshold inside a recurring operating line. It does not measure the company as a whole.

Company anatomy

The contract is one rung beneath one operating line.

S&P 500 issuerMedtronicMDT

Operating lineCardiovascular organic revenue growthmixed · % · issuer reported

Exact rungQ1 2027 · above 7Issuer-reported result · Live and priced

Source and determination

Issuer-reported measure

Mapped directly from the dated frozen Kalshi company-KPI snapshot.

Frozen Kalshi settlement-source metadata · Sep 1, 2026 · cardiovascular organic revenue growth — captured settlement source

Market measure

Latest listed close under the captured Kalshi rules · Dec 30, 2026, 4:00 AM UTC